Why First American Financial Corporation (FAF) stock moved
First American Financial Corporation (FAF) shares fell 1.8% to $71.73 as of July 21, 2026, a modest decline from the prior close of $73.03. BestStocks flagged the session as a major change for FAF. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for FAF, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
FAF fell 1.8% to $71.73
FAF fell 1.8% in its latest session, moving from $73.03 to $71.73.
What it means for First American Financial Corporation investors
For First American Financial Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: First American Financial Corporation (FAF) moved +1.42% from $72.01 to $73.03 on 2026-07-17; First American Financial Corporation (FAF) moved +3.51% from $69.57 to $72.01 on July 16, 2026. Weighing against that: Negative session, down 1.8%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $83.00, implying +15.7% upside from $71.73. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 1 days out, the next report is the most likely near-term test of the move.
FAF price reaction
FAF last traded at $71.73, down $1.30 (-1.78%) from the previous close of $73.03. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $65.41 and $73.03, and it currently sits about 83% of the way up that band.
Bullish and bearish analyst opinions on First American Financial Corporation (FAF)
The consensus analyst price target on First American Financial Corporation (FAF) is $83.00, 15.7% above the recent $71.73. Over the past 90 days analysts logged 0 upgrades, 6 maintains, and 0 downgrades. Here is how the bullish and bearish cases on FAF line up.
The bullish case
- Wall Street's consensus price target of $83.00 implies +15.7% upside from $71.73.
- The Street's most bullish target is $85.00 (+18.5%).
- First American Financial Corporation (FAF) moved +1.42% from $72.01 to $73.03 on 2026-07-17.
- Positive price momentum.
The bearish case
- Negative session, down 1.8%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for FAF
Frequently asked questions about FAF
Why did First American Financial Corporation (FAF) stock move?
FAF fell 1.8% to $71.73. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did FAF stock fall?
FAF lost 1.78% ($1.30) versus the prior close of $73.03, last trading at $71.73 on 0.8× average volume.
When is First American Financial Corporation's next earnings date?
FAF's next earnings report is estimated for 2026-07-22 — about 1 day away.
What is the analyst price target for FAF?
The consensus analyst price target for FAF is $83.00, about 15.7% above the current $71.73. Over the past 90 days, analysts recorded 0 upgrades, 6 maintains, and 0 downgrades.
How BestStocks tracks FAF
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared FAF-specific materiality thresholds, triggering an evidence check. It draws on 5 tracked change events for FAF, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.